Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Tablets × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Polycystic Ovary Syndrome 3 Endometrial Neoplasms 3 Sarcoma 2 Obesity 2 Neoplasms 2 Inflammation 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Weight Gain 1 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Mesothelioma 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡